Poulvac Bursa Plus Lyophilisate for suspension in drinking water
Poulvac Bursa Plus Lyophilisate for suspension in drinking water
Authorised
- Infectious bursal disease virus, strain V877, Live
Product identification
Medicine name:
Poulvac Bursa Plus Lyophilisate for suspension in drinking water
Poulvac Bursa Plus Lyophilisate for suspension in drinking water
Active substance:
- Infectious bursal disease virus, strain V877, Live
Target species:
-
Chicken
Route of administration:
-
In drinking water use
Product details
Active substance and strength:
-
Infectious bursal disease virus, strain V877, Live2511.8950% Embryo Infective Dose1.00Dose
Pharmaceutical form:
-
Lyophilisate for suspension
Withdrawal period by route of administration:
-
In drinking water use
- Chicken
-
Egg0day
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD09
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- (ID6): 1 Box with 10 Bottle (Glass) with 5000 Dose (50000 Dose)
- (ID5): 1 Box with 10 Bottle (Glass) with 2000 Dose (20000 Dose)
- (ID4): 1 Box with 10 Bottle (Glass) with 1000 Dose (10000 Dose)
- (ID3): 1 Box with 1 Bottle (Glass) with 5000 Dose (5000 Dose)
- (ID2): 1 Box with 1 Bottle (Glass) with 2000 Dose (2000 Dose)
- (ID1): 1 Box with 1 Bottle (Glass) with 1000 Dose (1000 Dose)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
- HPRA
Authorisation number:
- VPA10387/049/001
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0278/001
Concerned member states:
-
Belgium
-
Greece
-
Ireland
-
Italy
-
Lithuania
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovenia
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 9/08/2022
German (PDF)
Published on: 28/01/2022
How useful was this page?: